These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3733389)

  • 1. Investigative studies in the diagnosis and treatment of melanoma.
    Seigler HF
    Invest Radiol; 1986 Jul; 21(7):596-600. PubMed ID: 3733389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical application of monoclonal antibodies to human malignant melanoma-associated antigens].
    Kageshita T; Ishihara K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1744-8. PubMed ID: 3899015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [To outwit melanoma with its own tricks].
    Bischoff A
    MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant melanoma].
    Schmid-Wendtner M; Wendtner CM
    Dtsch Med Wochenschr; 2012 Dec; 137(49):2548-50. PubMed ID: 23188634
    [No Abstract]   [Full Text] [Related]  

  • 5. Pitfalls in the clinical application of monoclonal antibodies in malignant melanoma: modulation by and impaired accessibility of antigens to monoclonal antibodies.
    Tilgen W; Matzku S
    Cancer Treat Rev; 1990 Sep; 17(2-3):357-71. PubMed ID: 2272052
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunology and immunotherapy of human malignant melanoma.
    Bystryn JC
    Dermatol Clin; 1985 Apr; 3(2):327-34. PubMed ID: 2937585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphangiogenesis: implications for diagnosis, treatment, and prognosis in patients with melanoma.
    Pastushenko I; Conejero C; Carapeto FJ
    Actas Dermosifiliogr; 2015; 106(1):7-16. PubMed ID: 24890812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in melanoma.
    Feld E; Mitchell TC
    Immunotherapy; 2018 Aug; 10(11):987-998. PubMed ID: 30149766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dummer R; Hauschild A; Guggenheim M; Keilholz U; Pentheroudakis G;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii86-91. PubMed ID: 22997461
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
    de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
    J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Round table on: Melanoma: problems of therapy].
    Minerva Chir; 1985 Jun; 40(12):921-42. PubMed ID: 4034005
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy of melanoma.
    Chapman PB
    Cancer Chemother Biol Response Modif; 2002; 20():371-83. PubMed ID: 12703215
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlling melanoma at local and systemic levels: is a combination of ablative therapy and immunotherapy the way forward?
    Almeida JP; Drezek RA; Foster AE
    Immunotherapy; 2014; 6(2):109-11. PubMed ID: 24491082
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical Options for the Adjuvant Treatment and Management of Pediatric Melanoma.
    Raef HS; Friedmann AM; Hawryluk EB
    Paediatr Drugs; 2019 Apr; 21(2):71-79. PubMed ID: 30924056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine.
    Hsueh EC; Morton DL
    Semin Cancer Biol; 2003 Dec; 13(6):401-7. PubMed ID: 15001158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple primary melanoma.
    Moseley HS; Giuliano AE; Storm FK; Clark WH; Robinson DS; Morton DL
    Cancer; 1979 Mar; 43(3):939-44. PubMed ID: 427733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of preoperative lymphoscintigraphy in surgery planning for sentinel lymph node biopsy in malignant melanoma.
    Vucetić B; Andreja Rogan S; Balenović A; Ivkić M; Situm M; Hudorović N; Kusić Z
    Wien Klin Wochenschr; 2006 May; 118(9-10):286-93. PubMed ID: 16810487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.
    Thompson JJ; Herlyn MF; Elder DE; Clark WH; Steplewski Z; Koprowski H
    Am J Pathol; 1982 Jun; 107(3):357-61. PubMed ID: 6177248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging strategies for the treatment of metastatic melanoma: the role of monoclonal antibodies in targeted immunotherapy. Introduction.
    Trinh VA; Poust J
    Am J Health Syst Pharm; 2008 Dec; 65(24 Suppl 9):S1-2. PubMed ID: 19052262
    [No Abstract]   [Full Text] [Related]  

  • 20. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.